Company Filing History:
Years Active: 2020
Title: Innovations by Sang Tae Park
Introduction
Sang Tae Park is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of vaccine development, particularly in enhancing immune responses against influenza viruses. His work is crucial in the ongoing fight against viral diseases.
Latest Patents
Sang Tae Park holds a patent for an "Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same." This invention relates to an adjuvant composition that includes at least one binding molecule for neutralizing the influenza virus. The composition is designed to increase the effectiveness of vaccines, thereby enhancing the immune response upon administration. This innovation is particularly useful in preventing diseases caused by viruses.
Career Highlights
Sang Tae Park is associated with Celltrion Inc., a prominent biopharmaceutical company. His work at Celltrion focuses on developing advanced therapeutic solutions that address critical health challenges. His expertise in vaccine technology has positioned him as a key figure in the field.
Collaborations
Sang Tae Park collaborates with talented professionals, including Shin Jae Chang and Soo Young Lee. These collaborations enhance the research and development efforts at Celltrion Inc., fostering innovation in vaccine technology.
Conclusion
Sang Tae Park's contributions to vaccine development and his innovative patent highlight his importance in the field of immunology. His work continues to pave the way for advancements in preventing viral diseases.